Cargando…
Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research
Castleman disease (CD) is a rare and heterogeneous disorder characterized by lymphadenopathy that may occur in a single lymph node (unicentric) or multiple lymph nodes (multicentric), the latter typically occurring secondary to excessive proinflammatory hypercytokinemia. While a cohort of multicentr...
Autores principales: | Newman, Samantha Kass, Jayanthan, Raj K., Mitchell, Grant W., Carreras Tartak, Jossie A., Croglio, Michael P., Suarez, Alexander, Liu, Amy Y., Razzo, Beatrice M., Oyeniran, Enny, Ruth, Jason R., Fajgenbaum, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654187/ https://www.ncbi.nlm.nih.gov/pubmed/26604862 |
Ejemplares similares
-
The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease
por: Horna, Pedro, et al.
Publicado: (2022) -
A model for crowdsourcing high-impact research questions for Castleman disease and other rare diseases
por: Korsunska, Ania, et al.
Publicado: (2023) -
Incorporation of a Case-based Health Equity Curriculum into Morbidity and Mortality Conference
por: Carreras Tartak, Jossie A., et al.
Publicado: (2023) -
Racial Differences in Triage for Emergency Department Patients with Subjective Chief Complaints
por: Peitzman, Cassandra, et al.
Publicado: (2023) -
AA amyloidosis associated with Castleman disease: A case report and review of the literature
por: Bernabei, Luca, et al.
Publicado: (2020)